Convergence of the two pandemics: metabolic syndrome and COVID-19 over last two years
has posed unprecedented challenges to individuals as well as healthcare systems …

Abstract Coronavirus disease 2019 (COVID-19) is primarily a respiratory disease with multi-
organ involvement, including impaired liver function. It has been noticed that a significant …

The proposed research study accentuates the delivery of drug and natural bioenhancer by
utilizing a nano-platform based on eudragit RL (ERL) for enhanced efficacy, bioavailability …

Alcohol use disorder is a complex and heterogeneous phenomenon that can be studied
from several points of view by focusing on its different components. Alcohol is a hepatotoxin …

In late December 2019, severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-
2) was discovered following a cluster of pneumonia cases in Wuhan, China. During the early …

The 2019 novel coronavirus disease (COVID-19) has lasted for over 3 years and has
seriously affected the regular life trajectory of human beings. The severe acute respiratory …

Background: No specific drug for COVID-19 has been found, and many studies have found
that different degrees of liver injury often occurred after infection with COVID-19. Glycyrrhizic …

Introduction Liver involvement in COVID-19 is multifactorial, and the three potential
mechanisms are direct hepatocyte viral damage, vascular or cellular damage during the …

SARS-CoV-2 infection may affect the liver in healthy individuals but also influences the
course of COVID-19 in patients with chronic liver disease (CLD). As described in healthy …

The effects of coronavirus disease 2019 (COVID-19) primarily concern the respiratory tract
and lungs; however, studies have shown that all organs are susceptible to infection by …